DocGo Inc. (DCGO)
| Market Cap | 35.54M -75.5% |
| Revenue (ttm) | 294.72M -32.4% |
| Net Income | -192.42M |
| EPS | -1.96 |
| Shares Out | 98.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,438,350 |
| Open | 0.3720 |
| Previous Close | 0.3731 |
| Day's Range | 0.3580 - 0.3799 |
| 52-Week Range | 0.3450 - 1.6500 |
| Beta | 0.94 |
| Analysts | Buy |
| Price Target | 1.88 (+423.39%) |
| Earnings Date | Aug 17, 2026 |
About DCGO
DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, m... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for DCGO stock is "Buy." The 12-month stock price target is $1.88, which is an increase of 423.39% from the latest price.
News
DocGo Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
The event highlighted strong growth in mobile health and telehealth, a clear path to profitability through service line optimization and automation, and strategic expansion via acquisitions like Hicuity Health. Technology integration and outcomes-based care are central to scaling and improving margins.
DocGo Slides: Investor presentation
DocGo has posted slides in relation to its latest quarterly earnings report, which was published on September 7, 2026.
DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Ex...
DocGo Earnings Call Transcript: Q2 2026
Q2 2026 saw record volumes in core business lines, a major acquisition (Hicuity Health), and new funding, despite a year-over-year revenue decline due to the wind-down of migrant projects. Adjusted EBITDA loss improved sequentially, and full-year guidance was narrowed, with positive EBITDA run rate expected by year-end.
DocGo Earnings release: Q2 2026
DocGo released its Q2 2026 earnings on August 17, 2026, summarizing the period's financial results.
DocGo Quarterly report: Q2 2026
DocGo has published its Q2 2026 quarterly earnings report on August 17, 2026.
DocGo enters agreement to acquire Hicuity Health
DocGo (DCGO) has entered into a definitive agreement to acquire 100% of virtual care provider, Hicuity Health. DocGo is acquiring Hicuity in exchange for the assumption of the company’s existing…
DocGo reports Q2 EPS (16c), consensus (36c)
Reports Q2 revenue $73.4M, consensus $75.57M. “The continued evolution of our company into the premier provider of virtual, remote, and in-home healthcare at any address took a major leap forward…
DocGo narrows FY26 revenue view to $305M-$310M from $300M-$315M
Consensus $305.12M. Guidance does not include any contribution from the acquisition of Hicuity Health, as the transaction has not yet closed.
DocGo Announces Second Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial a...
DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Co...
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
DocGo Transcript: AGM 2026
The meeting covered board transitions, approval of key proposals, and strong financial performance, including record growth in core business lines and successful acquisitions. Strategic initiatives focus on technology-driven efficiency and integrated care, with ongoing exploration of shareholder value alternatives.
DocGo Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
The business has shifted from emergency response to a scalable, technology-driven healthcare delivery model, focusing on in-home, virtual, and transportation services. Integration of SteadyMD and the Care Anywhere platform is driving efficiency, margin improvement, and growth, while regulatory changes and payer partnerships support a path to profitability and long-term expansion.
DocGo launches mobile phlebotomy services in South Florida
DocGo (DCGO) announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship wi...
DocGo Launches Mobile Phlebotomy Services in South Florida
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PT...
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Ex...
DocGo Transcript: 21st Annual Needham Technology, Media, & Consumer Conference
The conference highlighted strong growth in tech-driven mobile healthcare, with significant expansion in medical transportation and care in the home. Financial guidance was raised, with a clear path to profitability, and operational improvements are underway. The company is leveraging technology and strategic partnerships to drive efficiency and growth.
DocGo reports Q1 EPS (15c), two estimates (6c)
Reports Q1 revenue $75.6M, consensus $72.4M. Lee Bienstock, Chief Executive Officer of DocGo (DCGO), commented, “We continued to experience strong volumes across all key business verticals, and especi...
DocGo Earnings Call Transcript: Q1 2026
Q1 2026 saw $75.6M revenue and strong growth in virtual care and medical transportation, offset by higher labor and fuel costs. 2026 revenue guidance was raised to $300M-$315M, with margin improvement expected as cost cuts take effect.
DocGo Earnings release: Q1 2026
DocGo released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.
DocGo Quarterly report: Q1 2026
DocGo has published its Q1 2026 quarterly earnings report on May 11, 2026.
DocGo Announces First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial a...
DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that Lee Bienstock, Chief Ex...
DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Co...